Real-world assessment of clinical outcomes among first-line (1L) sunitinib (SUN) patients (pts) with metastatic renal cell carcinoma (mRCC) by the international mRCC database consortium (IMDC) risk group.

被引：1
|
作者：
Savard, Marie-France
Wells, J. Connor
Graham, Jeffrey
Steinharter, John A.
McGregor, Bradley Alexander
Donskov, Frede
Bjarnason, Georg A.
Vaishampayan, Ulka N.
Hansen, Aaron Richard
Iafolla, Marco Adelmo James
Zanotti, Giovanni
Huynh, Lynn
Duh, Mei Sheng
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[5] Karmanos Canc Inst, Detroit, MI USA
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Pfizer Inc, New York, NY USA
[8] Anal Grp Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
610
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world assessment of clinical outcomes among first-line (1 L) Sunitinib patients with metastatic renal cell carcinoma (MRCC) by the international Mrcc database consortium (IMDC) risk group
    Lynn Huynh
    Savard, Marie-France
    Wells, J. Connor
    Graham, Jeffrey
    Steinharter, John
    McGregor, Bradley
    Donskov, Frede
    Bjarnason, Georg A.
    Vaishampayan, Ulka
    Hansen, Aaron
    Iafolla, Marco
    Zanotti, Giovanni
    Nguyen, Catherine
    Chang, Rose
    Duh, Mei S.
    Heng, Daniel Y. C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 124 - 125
  • [2] Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group
    Savard, Marie-France
    Wells, J. Connor
    Graham, Jeffrey
    Dudani, Shaan
    Steinharter, John A.
    McGregor, Bradley A.
    Donskov, Frede
    Bjarnason, Georg A.
    Vaishampayan, Ulka N.
    Hansen, Aaron R.
    Iafolla, Marco A. J.
    Zanotti, Giovanni
    Huynh, Lynn
    Chang, Rose
    Duh, Mei S.
    Heng, Daniel Y. C.
    [J]. ONCOLOGIST, 2020, 25 (05): : 422 - 430
  • [3] Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC).
    Ferrier, Evan
    Lemelin, Audreylie
    Powles, Thomas
    Pal, Sumanta Kumar
    Ebrahimi, Hedyeh
    Agarwal, Neeraj
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Wood, Lori
    Canil, Christina M.
    Saliby, Renee Maria
    de Velasco, Guillermo
    Mckay, Rana R.
    Tran, Ben
    Suarez, Cristina
    Templeton, Arnoud J.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 395 - 395
  • [4] CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL
    Huynh, L.
    Wells, J. C.
    Graham, J.
    Steinharter, J.
    McGregor, B.
    Donskov, F.
    Bjarnason, G. A.
    Vaishampayan, U.
    Hansen, A.
    Iafolla, M.
    Zanotti, G.
    Chang, R.
    Cheng, W. Y.
    Duh, M. S.
    Heng, D. Y. C.
    [J]. VALUE IN HEALTH, 2019, 22 : S59 - S60
  • [5] Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Gan, Chun Loo
    Dudani, Shaan
    Wells, Connor J.
    Schmidt, Andrew Lachlan
    Bakouny, Ziad
    Szabados, Bernadett
    Parnis, Francis
    Wong, Shirley
    Lee, Jae-Lyun
    de Velasco, Guillermo
    Pal, Sumanta K.
    Davis, Ian D.
    Kanesvaran, Ravindran
    Wood, Lori
    Kollmannsberger, Christian K.
    McKay, Rana R.
    Beuselinck, Benoit
    Donskov, Frede
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [6] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Brugarolas, James
    Broom, Reuben James
    Bamias, Aristotelis
    Yuasa, Takeshi
    Srinivas, Sandhya
    Ernst, D. Scott
    Pezaro, Carmel Jo
    Wood, Lori
    Kollmannsberger, Christian K.
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Gan, Chun Loo
    Wells, J. Connor
    Schmidt, Andrew Lachlan
    Powles, Thomas
    Tran, Ben
    Meza, Luis A.
    Labaki, Chris
    Lee, Jae-Lyun
    Wood, Lori
    Shapiro, Julia
    Ernst, D. Scott
    Kapoor, Anil
    Canil, Christina M.
    Yuasa, Takeshi
    McKay, Rana R.
    Beuselinck, Benoit
    Donskov, Frede
    Dudani, Shaan
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Swierkowski, Marcin
    Wells, Connor
    Fraccon, Anna Paola
    La Russa, Francesca
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Beuselinck, Benoit
    Wood, Lori
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] First-line (1L) immuno-oncology (10) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).
    Dudani, Shaan
    Graham, Jeffrey
    Wells, Connor
    Bakouny, Ziad
    Pal, Sumanta K.
    Dizman, Nazli
    Donskov, Frede
    Porta, Camillo
    de Velasco, Guillermo
    Hansen, Aaron Richard
    Iafolla, Marco Adelmo James
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Wood, Lori
    Liow, Elizabeth Chien Hern
    Yan, Flora
    Yuasa, Takeshi
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345